Regret Lottery for Hypertension

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Hypertension+1 More
Regret Lottery - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is designed to improve regulation of blood pressure by using a lottery incentive program to promote adherence to antihypertensive medication delivered via smartphone.

Eligible Conditions
  • Hypertension
  • Hypertensive disease

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Baseline, 6 months, and 12 months

12 Months
Adherence
Depression will be measured (baseline) by the PHQ-9
Patient-reported health status will be measured (baseline) using the Short Form 12 (SF-12).
Self-efficacy measured by the Medication Adherence Self Efficacy Scale (MASES)
Baseline
Comorbidity burden will be evaluated (baseline) using the Charlson Comorbidity Index (CCI)
Month 12
Motivation measured with the Treatment Self-Regulation Questionnaire (TSRQ)
baseline to 12 Months
Change in Systolic Blood Pressure (SBP)

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Regret lottery
1 of 2
Control Condition
1 of 2

Experimental Treatment

Non-Treatment Group

435 Total Participants · 2 Treatment Groups

Primary Treatment: Regret Lottery · Has Placebo Group · N/A

Regret lottery
Behavioral
Experimental Group · 1 Intervention: Regret Lottery · Intervention Types: Behavioral
Control Condition
Behavioral
PlaceboComparator Group · 1 Intervention: Control Condition · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Regret Lottery
2009
N/A
~640

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 6 months, and 12 months

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,255 Previous Clinical Trials
743,396 Total Patients Enrolled
38 Trials studying Hypertension
14,663 Patients Enrolled for Hypertension
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,580 Previous Clinical Trials
46,968,561 Total Patients Enrolled
440 Trials studying Hypertension
2,121,395 Patients Enrolled for Hypertension
John DodsonPrincipal InvestigatorNew York Langone Health

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The person has to take ≥1 antihypertensive medication from the following classes: thiazide diuretic, ACE inhibitor, angiotensin receptor blocker, beta blocker, calcium channel blocker, centrally acting alpha agonist, direct vasodilator.
If someone is taking medication for their blood pressure and their systolic blood pressure is 140 mmHg or higher, they are considered to have ambulatory hypertension.
You have a diagnosis of hypertension.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 31st, 2021

Last Reviewed: November 20th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
New York66.7%
California33.3%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Met criteria50.0%
Did not meet criteria50.0%